Caroline Gordon

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. pmc Numerical scoring for the Classic BILAG index
    Lynne Cresswell
    MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
    Rheumatology (Oxford) 48:1548-52. 2009
  2. pmc The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey
    Caroline Gordon
    Rheumatology Research Group, School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 52:2292-301. 2013
  3. pmc Managing pregnancy in inflammatory rheumatological diseases
    Varsha Jain
    Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Dudley Road, Birmingham B187QH, UK
    Arthritis Res Ther 13:206. 2011
  4. pmc Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis
    Karim Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Arthritis Res Ther 8:R120. 2006
  5. pmc Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin
    Karim Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Arthritis Res Ther 7:R784-95. 2005
  6. doi request reprint Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus
    C Gordon
    Department of Rheumatology, Division of Immunity and Infection East Wing, The Medical School, University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 47:334-8. 2008
  7. doi request reprint EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
    C Gordon
    Rheumatology Research Group, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Ann Rheum Dis 68:470-6. 2009
  8. ncbi request reprint Pregnancy and autoimmune diseases
    Caroline Gordon
    Department of Rheumatology, Division of Immunity, Infection, The Medical School, University of Birmingham, Birmingham, UK
    Best Pract Res Clin Rheumatol 18:359-79. 2004
  9. ncbi request reprint Pregnancy and rheumatic diseases
    M Gayed
    Department of Rheumatology, Division of Immunity and Infection East Wing, The Medical School University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 46:1634-40. 2007
  10. ncbi request reprint Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome
    C Gordon
    Department of Rheumatology, University of Birmingham, UK
    Lupus 7:429-33. 1998

Detail Information

Publications65

  1. pmc Numerical scoring for the Classic BILAG index
    Lynne Cresswell
    MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
    Rheumatology (Oxford) 48:1548-52. 2009
    ..To develop an additive numerical scoring scheme for the Classic BILAG index...
  2. pmc The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey
    Caroline Gordon
    Rheumatology Research Group, School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 52:2292-301. 2013
    ..The objective of this study was to explore the burden of SLE and its effect on patients' lives...
  3. pmc Managing pregnancy in inflammatory rheumatological diseases
    Varsha Jain
    Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Dudley Road, Birmingham B187QH, UK
    Arthritis Res Ther 13:206. 2011
    ..Vaginal delivery is possible in most circumstances, with cesarean section being reserved for complications...
  4. pmc Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis
    Karim Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Arthritis Res Ther 8:R120. 2006
    ..g. IL-2, IL-4, IL-15 GMCSF, GCSF). It is likely that this process contributes to an accumulation of leukocytes in the early rheumatoid lesion and is involved in the development of the microenvironment required for persistent RA...
  5. pmc Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin
    Karim Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Arthritis Res Ther 7:R784-95. 2005
    ..The cytokines present in the early rheumatoid lesion suggest that this response is likely to influence the microenvironment required for persistent RA...
  6. doi request reprint Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus
    C Gordon
    Department of Rheumatology, Division of Immunity and Infection East Wing, The Medical School, University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 47:334-8. 2008
    ..The aim of this study was to test the efficacy of testosterone patches vs placebo in female SLE patients with baseline mild-to-moderate disease activity in a randomized, double-blind, single-centre placebo-controlled trial...
  7. doi request reprint EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
    C Gordon
    Rheumatology Research Group, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    Ann Rheum Dis 68:470-6. 2009
    ..Systemic lupus erythematosus (SLE) is a complex multi-organ disease, characterised by relapses and remissions...
  8. ncbi request reprint Pregnancy and autoimmune diseases
    Caroline Gordon
    Department of Rheumatology, Division of Immunity, Infection, The Medical School, University of Birmingham, Birmingham, UK
    Best Pract Res Clin Rheumatol 18:359-79. 2004
    ..There have been very few meta-analyses or randomized clinical trials...
  9. ncbi request reprint Pregnancy and rheumatic diseases
    M Gayed
    Department of Rheumatology, Division of Immunity and Infection East Wing, The Medical School University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 46:1634-40. 2007
    ..Premature delivery may need to be planned to reduce the risks of stillbirth and can be associated with a variety of neonatal complications. Post-partum flare is common in all the rheumatic diseases...
  10. ncbi request reprint Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome
    C Gordon
    Department of Rheumatology, University of Birmingham, UK
    Lupus 7:429-33. 1998
    ..The addition of intravenous immunoglobulin therapy offers a low risk strategy for reducing autoantibody mediated disease and improving placental function in severely compromised, growth restricted pregnancies...
  11. ncbi request reprint Definition and treatment of lupus flares measured by the BILAG index
    C Gordon
    Department of Rheumatology, University of Birmingham, Edgbaston, Birmingham, UK
    Rheumatology (Oxford) 42:1372-9. 2003
    ..Secondly we wanted to establish whether patients with a new B score preceded by a C should be considered to have flared, as with patients scoring B following a D or E score...
  12. pmc The BILAG-2004 index is sensitive to change for assessment of SLE disease activity
    Chee Seng Yee
    Rheumatology Research Group, University of Birmingham, Birmingham, UK
    Rheumatology (Oxford) 48:691-5. 2009
    ..To determine if the BILAG-2004 index is sensitive to change for assessment of SLE disease activity...
  13. pmc Numerical scoring for the BILAG-2004 index
    Chee Seng Yee
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, The Medical School, University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 49:1665-9. 2010
    ..To develop an additive numerical scoring scheme for the BILAG-2004 index...
  14. pmc British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus
    Chee Seng Yee
    Department of Rheumatology, Division of Infection and Immunity, Medical School, University of Birmingham, Birmingham, UK
    Arthritis Rheum 56:4113-9. 2007
    ..To determine the construct and criterion validity of the British Isles Lupus Assessment Group 2004 (BILAG-2004) index for assessing disease activity in systemic lupus erythematosus (SLE)...
  15. pmc The BILAG-2004 systems tally--a novel way of representing the BILAG-2004 index scores longitudinally
    Chee Seng Yee
    Department of Rheumatology, Doncaster Royal Infirmary, Armthorpe Road, Doncaster DN2 5LT, UK
    Rheumatology (Oxford) 51:2099-105. 2012
    ..This was an exploratory analysis to develop a new way of representing BILAG-2004 system scores longitudinally that would be clinically meaningful and easier to analyse in comparison with multiple categorical variables...
  16. ncbi request reprint Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity
    Chee Seng Yee
    University of Birmingham, Birmingham, UK
    Arthritis Rheum 54:3300-5. 2006
    ..To test the interrater reliability of the revised British Isles Lupus Assessment Group 2004 (BILAG-2004) index for the assessment of systemic lupus erythematosus (SLE) activity...
  17. pmc The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients
    Chee Seng Yee
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, The Medical School East Wing, University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 50:982-8. 2011
    ..To examine SLEDAI-2000 cut-off scores for definition of active SLE and to determine the sensitivity to change of SLEDAI-2000 for the assessment of SLE disease activity and minimal clinically meaningful changes in score...
  18. doi request reprint The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus
    Kathleen McElhone
    Department of Rheumatology, Administration Block, Level 1, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH, UK
    J Rheumatol 37:2273-9. 2010
    ....
  19. doi request reprint Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus
    Athiveeraramapandian Prabu
    Department of Rheumatology, Division of Infection and Immunology, University of Birmingham, Birmingham, UK
    Rheumatology (Oxford) 48:1506-11. 2009
    ..The prevalence of PAH in SLE in non-tertiary centres is uncertain. This study aims to estimate the point prevalence of PAH and identify risk factors for PAH in a large cohort of SLE patients...
  20. doi request reprint Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects
    Chee Seng Yee
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
    Best Pract Res Clin Rheumatol 23:457-67. 2009
    ..As a result, SLE-specific measures of HRQoL have been developed recently. This article looks at the recent updates and changes in the standardised assessment of disease activity and HRQoL in SLE...
  21. pmc The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients
    Chee Seng Yee
    Department of Rheumatology, Doncaster Royal Infirmary, Armthorpe Road, Doncaster DN2 5LT, UK
    Rheumatology (Oxford) 51:1877-80. 2012
    ..To assess the inter-rater reliability of the BILAG2004-Pregnancy index for assessment of SLE disease activity in pregnancy...
  22. ncbi request reprint Novel treatments for systemic lupus erythematosus
    Mary Gayed
    Sandwell and West Birmingham Hospitals NHS Trust, Department of Rheumatology, City Hospital, Birmingham, B18 7QH, UK
    Curr Opin Investig Drugs 11:1256-64. 2010
    ..In this review, these novel approaches to the treatment of SLE, including the potential of targeting cytokine pathways involved in autoimmunity, are discussed...
  23. doi request reprint Challenges of ethnicity in SLE
    Kanta Kumar
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, The University of Birmingham, Birmingham, UK
    Best Pract Res Clin Rheumatol 23:549-61. 2009
    ..Further research is required to identify the best approaches to improve patients' understanding about lupus and its treatments and to show that improving adherence does indeed improve long-term outcomes...
  24. pmc Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis
    Karim Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham, UK
    J Rheumatol 32:231-8. 2005
    ..To study the prognostic value of antibodies to cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF), alone and in combination, in patients with very early synovitis...
  25. doi request reprint Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin
    K Kumar
    Rheumatology Research Group, Division of Immunity and Infection, The University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 47:690-7. 2008
    ..To assess whether patients with RA and SLE who are of South Asian origin have different beliefs about medicines in general, and about DMARDs in particular, compared with patients of White British/Irish origin...
  26. ncbi request reprint Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis
    K Raza
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 42:976-9. 2003
    ..To compare the accuracy of palpation-guided and high frequency ultrasound-guided needle placement in small joints and to develop a technique to obtain synovial fluid from these joints for diagnosis and research...
  27. ncbi request reprint Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia
    S L Nuttall
    Department of Clinical Pharmacology, University of Birmingham, Birmingham, UK
    Rheumatology (Oxford) 42:758-62. 2003
    ..This study aimed to investigate markers of oxidative stress, lipid metabolism and inflammation as potential cardiovascular risk factors in women with SLE...
  28. ncbi request reprint Development and assessment of a World Wide Web site for systemic lupus erythematosus patient information
    S P Young
    Department of Rheumatology, University of Birmingham, UK
    Lupus 11:478-84. 2002
    ..The website tested can be found at: www.rheumatology.bham.ac.uk/lupus/intro.html...
  29. doi request reprint The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE
    Bridget Griffiths
    Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
    Rheumatology (Oxford) 49:723-32. 2010
    ..To determine whether low-dose ciclosporin was a more effective corticosteroid-sparing agent than AZA in patients with SLE...
  30. doi request reprint Refractory multisystem sarcoidosis responding to infliximab therapy
    Adam P Croft
    Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Dudley Road, Birmingham, UK
    Clin Rheumatol 31:1013-8. 2012
    ..Our experience supports the urgent need for randomized controlled clinical trials of anti-TNF therapy in refractory systemic sarcoidosis...
  31. ncbi request reprint Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus
    C S Yee
    University of Birmingham, UK
    Rheumatology (Oxford) 42:276-9. 2003
    ..To determine if there is any association between autoantibody profile and damage in a cohort of patients with systemic lupus erythematosus (SLE)...
  32. doi request reprint Experience with a Punjabi, Urdu and Hindi rheumatology telephone helpline
    Kanta Kumar
    Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
    Musculoskeletal Care 7:210-8. 2009
    ....
  33. doi request reprint Systemic lupus erythematosus: clinical presentations
    Paul P Smith
    Rheumatology Research Group, School of Immunity and Infection, University of Birmingham, Edgebaston, Birmingham, UK
    Autoimmun Rev 10:43-5. 2010
    ..The prognosis depends on the organs involved. There is an increased risk of premature atherosclerosis as a complication of lupus and this and infection are the most common causes of death in lupus patients...
  34. ncbi request reprint Ocular manifestations of systemic lupus erythematosus
    R R Sivaraj
    Academic Unit of Ophthalmology, Division of Immunity and Infection, University of Birmingham, UK
    Rheumatology (Oxford) 46:1757-62. 2007
    ..Hydroxychloroquine rarely causes ocular toxicity at doses under 6.5 mg/kg/day. When this has occurred, it has been associated with more than 5 years of drug exposure...
  35. pmc Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint
    Lakhvir K Assi
    Institute of Biomedical Research, University of Birmingham, Birmingham, UK
    Arthritis Rheum 56:1776-86. 2007
    ..This study was undertaken to investigate the expression of BLyS and regulation of BLyS release from the surface of neutrophils infiltrating the rheumatoid joint...
  36. ncbi request reprint BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000
    C S Yee
    Department of Rheumatology, Division of Immunity and Infection, The Medical School East Wing, University of Birmingham, Birmingham B15 2TT, UK
    Ann Rheum Dis 67:873-6. 2008
    ....
  37. ncbi request reprint Malignancy is increased in ANCA-associated vasculitis
    T Pankhurst
    Division of Medical Sciences, The Medical School, University of Birmingham, Birmingham, UK
    Rheumatology (Oxford) 43:1532-5. 2004
    ....
  38. doi request reprint New biologic therapy for systemic lupus erythematosus
    Hui Jen Ding
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, The Medical School, Vincent Drive, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Curr Opin Pharmacol 13:405-12. 2013
    ..New drugs in development are those targeting the co-stimulatory modulation, cytokines and the B and T cells. Of interest are epratuzumab, the interferon antagonists and peptide-based therapies...
  39. doi request reprint Causes and management of infertility in systemic lupus erythematosus
    Richard A Hickman
    Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
    Rheumatology (Oxford) 50:1551-8. 2011
    ..Knowledge of how these reproductive problems occur and its prevention/treatment in SLE patients should avert irreversible infertility as well as give hope to SLE patients with infertility...
  40. ncbi request reprint Candidate T cell epitopes of the human La/SSB autoantigen
    Marie L Davies
    The Medical School, University of Birmingham, UK
    Arthritis Rheum 46:209-14. 2002
    ..To identify T cell epitopes of the human La autoantigen involved in the generation of anti-Ro/La autoantibodies...
  41. doi request reprint European consensus statement on the terminology used in the management of lupus glomerulonephritis
    C Gordon
    Rheumatology Research Group, Division of Immunity and Infection, University of Birmingham, Birmingham, UK
    Lupus 18:257-63. 2009
    ..We believe this consensus approach provides agreed expert opinion to clinicians and will form the basis for optimising LN treatment...
  42. doi request reprint Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy
    R A Hickman
    Rheumatology Research Group, University of Birmingham, Edgbaston, Birmingham, UK
    Lupus 19:327-9. 2010
    ..This case suggests that rituximab-induced B-cell depletion may provide an important new therapeutic option for refractory cases of this devastating ocular complication...
  43. doi request reprint Effects of rituximab on resistant SLE disease including lung involvement
    J A Reynolds
    Department of Rheumatology, City Hospital, Birmingham, West Midlands, UK
    Lupus 18:67-73. 2009
    ..Rituximab appeared to stabilise and possibly improve progressive lung disease...
  44. pmc Prevalence and predictors of fragility fractures in systemic lupus erythematosus
    C S Yee
    Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK
    Ann Rheum Dis 64:111-3. 2005
    ..To establish the prevalence of reduced bone mineral density (BMD) and fractures, and risk factors for fractures, in a cross sectional study of a large cohort of patients with systemic lupus erythematosus (SLE)...
  45. ncbi request reprint Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome
    R Callaghan
    Rheumatology Department, Division of Immunity and Infection, The University of Birmingham, UK
    Rheumatology (Oxford) 46:105-11. 2007
    ..To analyse the healthcare usage, direct healthcare costs and predictors of cost in primary Sjögren's syndrome (PSS) in the UK and to compare the findings with the data from healthy control groups and rheumatoid arthritis (RA) patients...
  46. ncbi request reprint Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndrome
    M L Davies
    Rheumatology Department, Division of Immunity and Infection, University of Birmingham Medical School, Birmingham, UK
    Rheumatology (Oxford) 41:395-400. 2002
    ....
  47. ncbi request reprint Lupus and zoster
    Karen M J Douglas
    Department of Rheumatology, University Hospital Birmingham, Edgbaston, Birmingham, UK
    Lancet 362:616. 2003
  48. ncbi request reprint Unilateral varicella zoster virus ophthalmicus and contralateral acute retinal necrosis
    B N Matthews
    Academic Unit of Ophthalmology Division of Immunity and Infection The University of Birmingham, Birmingham, UK
    Eye (Lond) 16:778-80. 2002
    ..The ipsilateral retina was spared in each case. One patient had systemic lupus erythematosus (SLE) and the other Hodgkin's disease. Both patients were in remission at the time of presentation...
  49. ncbi request reprint Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists
    K Kumar
    Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, The University of Birmingham, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 46:1438-40. 2007
    ..To study the delay from the time of symptom onset to assessment by a Rheumatologist in patients with rheumatoid arthritis (RA) and to determine the contributions of patient and physician dependent factors to this delay...
  50. ncbi request reprint Long-term complications of systemic lupus erythematosus
    C Gordon
    Department of Rheumatology, Division of Immunity and Infection, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Rheumatology (Oxford) 41:1095-100. 2002
  51. pmc EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
    C S Yee
    Rheumatology, University of Birmingham, UK
    Ann Rheum Dis 63:525-9. 2004
    ....
  52. doi request reprint Lupus and cancer
    M Gayed
    Rheumatology Research Group, School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham, UK
    Lupus 18:479-85. 2009
    ..Last but not least, cervical dysplasia is a concern in women with SLE, particularly with exposure to immunosuppressants; routine screening for this complication should not be neglected...
  53. ncbi request reprint Impaired endothelial function in systemic lupus erythematosus
    M K Piper
    Department of Rheumatology, University of Birmingham, UK
    Lupus 16:84-8. 2007
    ..There was no relationship between endothelial function and the development of damage in any organ system, including the cardiovascular system during patient follow-up. Patients with SLE have impaired endothelial Lupus (2007) 16, 84-88...
  54. ncbi request reprint Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group
    Sean J Wollaston
    Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    J Rheumatol 31:2390-4. 2004
    ..We attempted to determine whether these validated instruments were useful components in characterizing response in the setting of a clinical trial...
  55. ncbi request reprint Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus
    Kathleen McElhone
    Royal Blackburn Hospital, Blackburn, UK
    Arthritis Rheum 57:972-9. 2007
    ..To develop and validate a disease-specific health-related quality of life (HRQOL) instrument for adults with systemic lupus erythematosus (SLE)...
  56. pmc Anti-inflammatory and immunosuppressive drugs and reproduction
    Monika Østensen
    Department of Rheumatology and Clinical Immunology Allergology, University Hospital of Bern, Switzerland
    Arthritis Res Ther 8:209. 2006
    ..Recommendations for drug treatment during pregnancy and lactation are given...
  57. ncbi request reprint The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs
    Pantelis Panopalis
    McGill University, Montreal, Que bec, Canada
    Arthritis Rheum 57:64-70. 2007
    ..In the present study, we compared cumulative indirect costs over 4 years in these patients...
  58. pmc Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus
    Chetan Mukhtyar
    Ann Rheum Dis 66:569-70. 2007
  59. ncbi request reprint Usefulness of the British Isles Lupus Assessment Group index in pediatric clinical trials: comment on the article by Ruperto et al
    David Isenberg
    Arthritis Rheum 54:2343-4. 2006
  60. ncbi request reprint A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al
    Matthew J Simmonds
    Arthritis Rheum 46:3109-10. 2002
  61. ncbi request reprint Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices
    Bridget Griffiths
    Freeman Hospital, Newcastle upon Tyne, UK
    Best Pract Res Clin Rheumatol 19:685-708. 2005
    ..In addition to the assessment of disease activity, the evaluation of damage using the validated SLICC/ACR damage index and health-related quality of life is advised for clinical research...
  62. ncbi request reprint Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response
    Michelle Petri
    Department of Rheumatology, Johns Hopkins University, Baltimore, Maryland 21205, USA
    Arthritis Rheum 58:1789-95. 2008
    ..To assess the degree to which physicians agree with each other and with ratings obtained with 3 existing responder indices, in rating the response to treatment of lupus nephritis...
  63. ncbi request reprint Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index
    Michelle Petri
    Department of Rheumatology, Johns Hopkins University, Baltimore, Maryland 21205, USA
    Arthritis Rheum 58:1784-8. 2008
    ..To develop a measure of renal activity in systemic lupus erythematosus and use it to develop a renal response index...
  64. ncbi request reprint Sequential therapies for proliferative lupus nephritis
    Chee Seng Yee
    N Engl J Med 350:2518-20; author reply 2518-20. 2004
  65. ncbi request reprint Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study
    Rupa Bessant
    University College London, London, UK
    Arthritis Rheum 55:892-9. 2006
    ..We compared the prevalence of conventional and lupus-specific risk factors in patients with SLE just before a cardiovascular event and in matched controls with SLE but no cardiovascular disease (CVD)...